TARIS Biomedical
A pharmaceutical company developing therapeutics for the treatment of bladder diseases
8
Funding Rounds
$113.1m
Money raised
Overview
A pharmaceutical company developing therapeutics for the treatment of bladder diseases
-
Website:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company TARIS Biomedical has raised a total of $46.8m in funding over 8 rounds.
Key Insights:
- TARIS Biomedical funding round, March 2013: $13.5m
- TARIS Biomedical Series B round: $18.3m
- TARIS Biomedical Series A round: $15m
- TARIS Biomedical Series B round, December 2017: $25m
- TARIS Biomedical Venture round, October 2015: $32m
- TARIS Biomedical Venture round, November 2012: $3.1m
- TARIS Biomedical Venture round, July 2010: $1.2m
- TARIS Biomedical Series A round, December 2009: $5m
TARIS Biomedical funding round, March 2013
$13.5m
TARIS Biomedical Series B round
$18.3m
TARIS Biomedical Series A round
$15m
TARIS Biomedical Series B round, December 2017
$25m
TARIS Biomedical Venture round, October 2015
$32m
TARIS Biomedical Venture round, November 2012
$3.1m
TARIS Biomedical Venture round, July 2010
$1.2m
TARIS Biomedical Series A round, December 2009
$5m
Industries
TARIS Biomedical is active in the following industries: